Regenxbio price target lowered to $22 from $25 at BofA
BofA analyst Alec Stranahan lowered the firm’s price target on Regenxbio (RGNX) to $22 from $25 and keeps a Buy rating on the ...
Recursion Pharmaceuticals price target lowered to $10 from $12 at BofA
BofA analyst Alec Stranahan lowered the firm’s price target on Recursion Pharmaceuticals (RXRX) to $10 from $12 and keeps a ...
The market's wobbling. Here are BlackRock's shields for the biggest risks.
But maybe of more use are the hedges the company with $11 trillion in assets has articulated for a number of concerns that are currently weighing on investors' minds, according to strategists led by ...
US Stocks To Open Higher As Futures Advance: Christopher Wood Expects Trump's Inflationary Policies To Hurt Market
U.S. stock futures advanced on Wednesday after closing lower on Tuesday. Futures of all four major indices rose in premarket ...
AppLovin’s Nasdaq-Topping 700% Rally Sets Up Challenging 2025
After a blistering rally at the end of last year, shares in AppLovin Corp. may be running out of steam. The stock fell 7% on ...
Channels TV56m
Two US-Based Nigerians Face 40-Year Jail Term Over $560,000 Romance Scam
The victim sent approximately $560,000 to various accounts in the United States, Canada, and Malaysia between January 2016 and April 2017.